Technetium (99mTc) mertiatide
Appearance
Clinical data | |
---|---|
Trade names | Technescan Mag3 |
License data | |
Routes of administration | Intravenous |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
Chemical and physical data | |
3D model (JSmol) | |
| |
|
Technetium (99mTc) mertiatide is a radiopharmaceutical medication used in nuclear medicine to image the kidneys.[1] It is a renal imaging agent that is given by intravenous injection.[1]
It was approved for medical use in the United States in June 1990.[2]
Medical uses
[edit]Technetium (99mTc) mertiatide is indicated for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi.[1]
Chemistry
[edit]The active ingredient, betiatide, is reconstituted with sodium pertechnetate 99mTc injection to form technetium (99mTc) mertiatide.[1]
References
[edit]- ^ a b c d e "Technescan Mag3- technescan tc 99m mertiatide injection, powder, lyophilized, for solution". DailyMed. 13 December 2022. Archived from the original on 2 February 2023. Retrieved 1 February 2023.
- ^ "Technescan Mag3: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Archived from the original on 13 December 2022. Retrieved 1 February 2023.